A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.

Clinical trial NCT05977322 · TERMINATED

Trial details

NCT number: NCT05977322
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma Gastroesophageal Adenocarcinoma Glioblastoma Multiforme

Start date: 2023-10-06
Primary completion: 2024-12-13
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.